Bayesian Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$2.8M |
| 2 |
Target
TGT
|
+$2.73M |
| 3 |
Lockheed Martin
LMT
|
+$2.7M |
| 4 |
Dollar Tree
DLTR
|
+$2.53M |
| 5 |
Northrop Grumman
NOC
|
+$2.29M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$2.59M |
| 2 |
Apple
AAPL
|
+$2.41M |
| 3 |
Conagra Brands
CAG
|
+$1.87M |
| 4 |
RHT
Red Hat Inc
RHT
|
+$1.67M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.45M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.61% |
| 2 | Consumer Discretionary | 19.21% |
| 3 | Industrials | 13.4% |
| 4 | Healthcare | 12.85% |
| 5 | Financials | 10.53% |
Similar funds
Bayesian Capital Management's Q4 2016 Portfolio in Review
As of Q4 2016, Bayesian Capital Management held 793 positions worth $403M, up 164% from $152M the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Bayesian Capital Management deployed $235M of net new capital in Q4 2016, opening 457 new positions and adding to 87 existing holdings. Its largest new stake was Procter & Gamble: 32,800 shares worth $2.76M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 26% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Zebra Technologies, an estimated $419K trimmed.
- Bayesian Capital Management's largest Q4 2016 buy was Procter & Gamble: 32,800 shares worth $2.76M.
- Bayesian Capital Management added most to Ross Stores in Q4 2016, an estimated $1.85M increase.
- Bayesian Capital Management's biggest Q4 2016 reduction was Zebra Technologies, cutting an estimated $419K.
- Bayesian Capital Management fully exited Adobe in Q4 2016, selling an estimated $2.59M.
- Bayesian Capital Management's ten largest holdings make up 6.3% of its $403M portfolio in Q4 2016.
- Bayesian Capital Management opened 457 new positions and closed 219 in Q4 2016.
- Bayesian Capital Management's portfolio value rose 164% quarter-over-quarter to $403M.
Based on Bayesian Capital Management's 13F filing for Q4 2016, filed 13 Feb 2017.